66th Annual Meeting of the German Society of Neurosurgery (DGNC)
Friendship Meeting with the Italian Society of Neurosurgery (SINch)
German Society of Neurosurgery (DGNC)
7 - 10 June 2015, Karlsruhe
Postersitzungen
P III Freie Themen II: Gliome experimentell
Meeting Abstract
(P 031)
[Full Text]
Element distribution analysis of glioma tissue and cells by using x-ray microscopy
Sachkova A, Ducic T, Sperling S, Grolimund D, Rohde V, Ninkovic M[Full Text]
Meeting Abstract
(P 032)
[Full Text]
CD133 expression is not synonymous with immunoreactivity for the diagnostic antibody AC133 and fluctuates throughout the cell cycle in glioma stem-like cells
Renovanz M, Barrantes-Freer A, Pardo L, Giese A, Kim EL[Full Text]
Meeting Abstract
(P 033)
[Full Text]
Expression of plasmolipin on glioma stem-like cells confers susceptibility to gene transduction using lentiviral McERV pseudotypes
Kim E, Renovanz M, Viehweg S, Giese A, Stocking C, Prassolov V[Full Text]
Meeting Abstract
(P 034)
[Full Text]
Role of co-chaperone BAG-1 in glioma
Müther M, Dohm C, Rave-Fränk M, Bähr M, Kermer P[Full Text]
Meeting Abstract
(P 035)
[Full Text]
E-cadherin propeptide modification potentially determines migratory and invasive behavior of glioma cells
Ritter S, Schackert G, Temme HA[Full Text]
Meeting Abstract
(P 036)
[Full Text]
Increased KIR4.1 immunoreactivity in human glioma tissue
Schirmer L, Ringel F, Butenschön VM, Srivastava R, Hemmer B, Gempt J[Full Text]
Meeting Abstract
(P 037)
[Full Text]
Alteration of FGF isoform expression in glioma patients of different WHO grades
Dreher L, Goldbrunner R, Timmer M[Full Text]
Meeting Abstract
(P 038)
[Full Text]
Differences in the expression of CD184, CD95, CD178 and CD40 in human gliomas of various grades, before and after chemotherapy
Werner J, Röhn G, Goldbrunner R, Timmer M[Full Text]
Meeting Abstract
(P 039)
[Full Text]
Anaplastic meningiomas WHO grade III lack of somatic AKT1-mutations and show an overexpression of EGF receptors
Juratli TA, Wiedemuth R, Geiger KD, Temme A, Kirsch M, Schackert G[Full Text]
Meeting Abstract
(P 040)
[Full Text]
A quantitative real-time PCR high resolution melting (HRM) method for evaluating the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in malignant gliomas is superior to conventional methylation specific PCR in predicting clinical outcome and survival in patients with malignant glioma
Switzeny OJ, Renovanz M, Sommer C, Christmann M, Giese A, Kaina B[Full Text]
Meeting Abstract
(P 041)
[Full Text]
No glow in the dark – why some gliomas are non-fluorescent: Histopathologic analysis of 140 high-grade gliomas
Hickmann AK, Nadji-Ohl M, Ganslandt O[Full Text]
Meeting Abstract
(P 042)
[Full Text]
Enhancement of the temozolomide effect with atorvastatin and pioglitazone on malignant glioma
Yildiz ÖC, Pérez JHT, Kirches E, Mawrin C, Schneider T[Full Text]
Meeting Abstract
(P 043)
[Full Text]
Overexpression of BIRC5/Survivin in glioma cells induces resistance against temozolomide and enhances tumorigenicity
Conde M, Düring I, Wiedemuth R, Schackert G, Temme A[Full Text]